IGFBP‐4 downregulates the SDF‐1 receptor CXCR4, and CXCR4 levels are elevated in primary pulmonary fibroblasts of patients with SSc‐associated pulmonary fibrosis. Here, IGFBP4 is linked to systemic sclerosis.